Wealth Architects »

Atara Biotherapeutics shares owned by Wealth Architects

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Wealth Architects from 13F filings

Historical chart of Wealth Architects investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Wealth Architects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Wealth Architects

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8k 13k 0.51
2023-09-30 $20k 13k 1.48
2023-06-30 $21k 13k 1.61
2023-03-31 $39k 13k 2.90
2022-12-31 $44k 13k 3.28
2022-09-30 $50k 13k 3.77

More positions owned by Wealth Architects

Ishares Tr Core S&p500 Etf (IVV)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Index Shs Fds S&p Gblinf Etf (GII)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Apple (AAPL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Internatnal Val (DFIV)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)

View all positions for Wealth Architects

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics